Skip to content

AdaptHealth AHCO Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
ResMed logo
ResMedRMD
Baxter International logo
Baxter InternationalBAX
Savara logo
SavaraSVRA

Other financials

Income statement

See full
Revenue$819.8M+5.4%
Gross profit$111.5M-7.4%
Operating income$5.5M-76.3%
Net income-$16.0M-123%
EPS (diluted)-$0.12-140%

Balance sheet

See full
Cash & equivalents$48.0M-10.6%
Total debt$2.0B-4.9%
Total equity$1.5B-3.9%
Total assets$4.4B-0.3%

Cash flow

See full
Operating cash flow$93.7M-1.9%
CapEx$121.2M+26.8%
Free cash flow-$27.5M-47,297%

Valuation

See full
Market cap$1.36B+20.5%
Enterprise value$3.32B+4.3%
P/S0.4×+0.1×

Profitability

See full
Gross margin18.3%-1.6pp
Operating margin8%+6.9pp
Net margin-2.4%-5.1pp
FCF margin5.8%-2.6pp

Returns & leverage

See full
Return on equity-5.2%-10.8pp
Debt / equity1.3×0.0×
Current ratio0.9×-0.4×

Where this comes from

Reported directly by AdaptHealth in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: AdaptHealth’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about AdaptHealth's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AdaptHealth's interest income (expense), nonoperating?
AdaptHealth (AHCO) reported interest income (expense), nonoperating of -$25.59M in Q1 2026.
How has AdaptHealth's interest income (expense), nonoperating changed year-over-year?
AdaptHealth's interest income (expense), nonoperating increased by 9.9% year-over-year, from -$28.4M to -$25.59M.
What is the long-term trend for AdaptHealth's interest income (expense), nonoperating?
Over 3 years (2022 to 2025), AdaptHealth's interest income (expense), nonoperating has grown at a -1.1% compound annual growth rate (CAGR), from -$109.41M to -$105.75M.